Table 1.
Total (%) | LR (%) | |
---|---|---|
Gender | ||
Male | 45(58%) | 14(67%) |
Female | 33(42%) | 7(33%) |
Race | ||
EA | 69(88%) | 17(81%) |
AA | 9(12%) | 4(19%) |
Smoking | ||
Yes | 47(60%) | 15(72%) |
No | 22(28%) | 3(14%) |
Unknown | 9(12%) | 3(14%) |
Alcohol | ||
Yes | 31(40%) | 10(48%) |
No | 33(42%) | 9(43%) |
Unknown | 14(18%) | 2(9%) |
T stage | ||
T1 | 26(33%) | 4(19%) |
T2 | 21(27%) | 4(19%) |
T3 | 13(17%) | 6(29%) |
T4 | 18(23%) | 7(33%) |
N stage | ||
N0 | 49(63%) | 11(52%) |
N1 | 10(13%) | 3(14%) |
N2 | 19(24%) | 7(34%) |
Treatment | ||
Sx | 45(58%) | 8(38%) |
Sx + RT | 18(23%) | 5(24%) |
Sx + CRT | 15(19%) | 8(38%) |
Registry Sites | ||
Buccal Mucosa | 11(14%) | 1(5%) |
Floor of Mouth | 6(8%) | 2(10%) |
Gingiva | 13(17%) | 2(10%) |
Retromolar trigone | 1(1%) | 0(0%) |
Tongue | 47(60%) | 16(75%) |
Note: Total, the entire cohort; LR, the locoregional recurrent cohort.